Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04RFX
|
|||
Former ID |
DIB012751
|
|||
Drug Name |
LFn-p24
|
|||
Synonyms |
WRAIR HIV vaccine
Click to Show/Hide
|
|||
Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 1 | [1] | |
Company |
Avant Immunotherapeutics
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00412477) A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.